M, D., R, C., C, B., A, B., T, N., W, W., . . . R, H. (2018). Application of High-Throughput Flow Cytometry in Early Drug Discovery: An AstraZeneca Perspective. SLAS discovery : advancing life sciences R & D, 23(7), 719. https://doi.org/10.1177/2472555218775074
Chicago Style (17th ed.) CitationM, Ding, Clark R, Bardelle C, Backmark A, Norris T, Williams W, Wigglesworth M, and Howes R. "Application of High-Throughput Flow Cytometry in Early Drug Discovery: An AstraZeneca Perspective." SLAS Discovery : Advancing Life Sciences R & D 23, no. 7 (2018): 719. https://doi.org/10.1177/2472555218775074.
MLA (9th ed.) CitationM, Ding, et al. "Application of High-Throughput Flow Cytometry in Early Drug Discovery: An AstraZeneca Perspective." SLAS Discovery : Advancing Life Sciences R & D, vol. 23, no. 7, 2018, p. 719, https://doi.org/10.1177/2472555218775074.